Effect of Vestibular Schwannoma Size and Nerve of Origin on Posterior External Auditory Canal Sensation: A Prospective Observational Study.


Journal

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504

Informations de publication

Date de publication:
10 2020
Historique:
entrez: 14 9 2020
pubmed: 15 9 2020
medline: 15 4 2021
Statut: ppublish

Résumé

Posterior external auditory canal (EAC) hypesthesia (Hitselberger's sign) has been previously described to occur in all vestibular schwannomas (1966) but has not been studied since. We hypothesized that sensory loss may be related to tumor size and sought to determine if this clinical sign could predict preoperative characteristics of vestibular schwannomas, intraoperative findings, and/or surgical outcomes. Prospective observational study. Tertiary referral center. Twenty-five consecutive patients who underwent surgery for vestibular schwannoma. Patients were tested for the presence of EAC hypesthesia or anesthesia. Preoperative, intraoperative, and postoperative findings were recorded, including facial nerve function, hearing function, tumor size, tumor nerve of origin, and extent of resection. Twelve patients (48%) demonstrated either posterior EAC hypesthesia (11 patients) or anesthesia (1 patient). Sensory loss was a significant predictor of size (tumor maximal diameter) (p = 0.004). Median tumor diameter was 1.7 cm in the cohort with intact sensation versus 2.9 cm in the cohort with sensory loss. Patients with sensory loss were also significantly more likely to be associated with a superior vestibular nerve origin tumor (p = 0.01). Preoperative sensory loss did not significantly predict postoperative facial outcome (p = 0.10). Neurological exam findings may be overlooked in the workup of brain tumors. Posterior EAC hypesthesia is a predictor of tumor size and superior vestibular nerve origin. These findings may have implications for patient selection, particularly with the middle cranial fossa approach. Furthermore, given this relationship with tumor size, this clinical biomarker should be studied as a potential predictor of tumor growth.

Identifiants

pubmed: 32925858
doi: 10.1097/MAO.0000000000002738
pii: 00129492-202010000-00030
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1145-e1148

Références

Hunt J. The cutaneous zone of the facial nerve. N Y Med J 1915; 102:777779.
Hitselberger WE, House WF. Acoustic neuroma diagnosis. External auditory canal hypesthesia as an early sign. Arch Otolaryngol 1966; 83:218221.
Mehta GU, Lekovic GP. The history of neurosurgery at the House Clinic in Los Angeles. J Neurosurg 2019; 17.
Eshraghi AA, Buchman CA, Telischi FF. Sensory auricular branch of the facial nerve. Otol Neurotol 2002; 23:393396.
House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93:146147.
Curtin HD, Hirsch WL Jr. Imaging of acoustic neuromas. Otolaryngol Clin North Am 1992; 25:553607.
Bennett AH. Case of cerebral tumour. Med Chir Trans 1885;68:243–75.
Takezawa K, Townsend G, Ghabriel M. The facial nerve: Anatomy and associated disorders for oral health professionals. Odontology 2018; 106:103116.
Gillig PM, Sanders RD. The trigeminal (V) and facial (VII) cranial nerves: Head and face sensation and movement. Psychiatry 2010; 7:2531.
Slattery WH, Brackmann DE, Hitselberger W. Middle fossa approach for hearing preservation with acoustic neuromas. Am J Otol 1997; 18:596601.
Goddard JC, Schwartz MS, Friedman RA. Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma. Otol Neurotol 2010; 31:11281134.
Pulec JL, House WF. Transtemporal bone microsurgical removal of acoustic neuromas. Facial nerve involvement and testing in acoustic neuromas. Arch Otolaryngol 1964; 80:685692.
Mehta GU, Huynh H, Lekovic GP. Peripheral nerve sheath tumors in Neurofibromatosis Type 2: Surgical and histopathologic features. Clin Neurol Neurosurg 2020; 190:105649.
Kline DG, Murovic JA, Kim DH, Tiel RL, Moes G. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg 2009; 102:246255.
Hofmeijer J, Franssen H, van Schelven LJ, van Putten MJAM. Why are sensory axons more vulnerable for ischemia than motor axons? PLoS One 2013; 8:e67113.

Auteurs

Gautam U Mehta (GU)

Division of Neurosurgery.

Gregory P Lekovic (GP)

Division of Neurosurgery.

Anne K Maxwell (AK)

Division of Neurotology, House Institute Foundation, Los Angeles, California.

Derald E Brackmann (DE)

Division of Neurotology, House Institute Foundation, Los Angeles, California.

William H Slattery (WH)

Division of Neurotology, House Institute Foundation, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH